🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 18 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/03/2009 | 4,80 | 5,20 | 4,75 | 4,90 | -3,92% | 9,38% | 3.440 |
| 11/03/2009 | 5,30 | 5,60 | 5,00 | 5,10 | -8,93% | 11,32% | 5.530 |
| 10/03/2009 | 5,50 | 5,80 | 5,25 | 5,60 | +5,66% | 10,00% | 7.050 |
| 09/03/2009 | 4,50 | 5,50 | 4,50 | 5,30 | +23,26% | 22,22% | 21.060 |
| 06/03/2009 | 4,40 | 5,00 | 4,10 | 4,30 | +19,44% | 20,45% | 12.670 |
| 05/03/2009 | 4,20 | 4,20 | 3,60 | 3,60 | +0,00% | 14,29% | 10.040 |
| 04/03/2009 | 3,60 | 3,90 | 3,60 | 3,60 | +0,00% | 8,33% | 7.370 |
| 03/03/2009 | 3,80 | 4,00 | 3,60 | 3,60 | -5,26% | 10,53% | 7.850 |
| 02/03/2009 | 4,00 | 4,20 | 3,70 | 3,80 | -2,56% | 12,50% | 6.190 |
| 27/02/2009 | 4,00 | 4,40 | 3,90 | 3,90 | -2,50% | 12,50% | 24.230 |
| 26/02/2009 | 4,00 | 4,40 | 3,90 | 4,00 | +2,56% | 12,50% | 25.140 |
| 25/02/2009 | 4,30 | 4,90 | 3,90 | 3,90 | -9,30% | 23,26% | 16.540 |
| 24/02/2009 | 3,90 | 5,00 | 3,70 | 4,30 | +4,88% | 33,33% | 18.860 |
| 23/02/2009 | 4,20 | 4,30 | 3,70 | 4,10 | -2,38% | 14,29% | 25.870 |
| 20/02/2009 | 4,50 | 4,90 | 4,10 | 4,20 | -26,32% | 17,78% | 47.520 |
| 19/02/2009 | 5,50 | 6,30 | 5,50 | 5,70 | +3,64% | 14,55% | 7.830 |
| 18/02/2009 | 5,60 | 5,78 | 5,20 | 5,50 | -2,48% | 10,36% | 14.320 |
| 17/02/2009 | 8,00 | 8,00 | 5,52 | 5,64 | -19,43% | 31,00% | 20.320 |
| 13/02/2009 | 7,10 | 7,20 | 7,00 | 7,00 | -2,78% | 2,82% | 6.780 |
| 12/02/2009 | 7,00 | 7,30 | 7,00 | 7,20 | -1,37% | 4,29% | 6.760 |
| 11/02/2009 | 8,00 | 8,00 | 7,15 | 7,30 | -6,41% | 10,63% | 8.790 |
| 10/02/2009 | 8,00 | 8,00 | 7,60 | 7,80 | -1,27% | 5,00% | 6.700 |
| 09/02/2009 | 8,10 | 8,40 | 7,80 | 7,90 | -4,82% | 7,41% | 5.810 |
| 06/02/2009 | 8,80 | 9,00 | 7,80 | 8,30 | -5,68% | 13,64% | 14.900 |
| 05/02/2009 | 8,40 | 9,00 | 8,10 | 8,80 | +6,02% | 10,71% | 10.820 |
| 04/02/2009 | 9,00 | 9,00 | 8,20 | 8,30 | -4,60% | 8,89% | 5.930 |
| 03/02/2009 | 9,00 | 9,11 | 8,50 | 8,70 | -3,33% | 6,78% | 8.920 |
| 02/02/2009 | 8,90 | 9,10 | 8,80 | 9,00 | +3,45% | 3,37% | 7.810 |
| 30/01/2009 | 8,70 | 9,20 | 8,70 | 8,70 | -2,25% | 5,75% | 16.310 |
| 29/01/2009 | 9,10 | 9,70 | 8,70 | 8,90 | +2,30% | 10,99% | 7.210 |